TMCnet News

Research and Markets: 2016 US POC/Point-of-Care Diagnostic Testing Market: Supplier Shares, Country Volume and Sales Segment Forecasts for 300 Tests
[November 19, 2015]

Research and Markets: 2016 US POC/Point-of-Care Diagnostic Testing Market: Supplier Shares, Country Volume and Sales Segment Forecasts for 300 Tests


Research and Markets (http://www.researchandmarkets.com/research/99tpkk/2016_us) has announced the addition of the "2016 US POC/Point-of-Care Diagnostic Testing Market: Supplier Shares, Country Volume and Sales Segment Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review, Competitive Strategies" report to their offering.

This new 1,172-page report contains 256 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies.

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:

- Home/Personal Testing



- Physician Offices/Group Practices

- Emergency Rooms


- Operating/Recovery Suites

- ICUs/CCUs

- Cancer Clinics

- Ambulatory Care Centers

- Surgery Centers

- Nursing Homes

- Birth Centers

By test category:

- Routine and Special Chemistry

- Microbiology/Infectious Diseases

- Hematology

- Flow Cytometry

- Coagulation

- Immunoproteins

- Drugs of Abuse

- TDM

- Endocrine Function

- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Companies Mentioned

- Abbott

- ADI/American Diagnostica/Sekisui

- Agilent Technologies

- Alere/Biosite/Inverness

- Axis (News - Alert)-Shield

- Beckman Coulter/Danaher

- Becton Dickinson

- Bio/Data

- Biomerieux

- Bio-Rad

- Cepheid

- Chrono-Log

- Corgenix

- Decode Genetics

For more information visit http://www.researchandmarkets.com/research/99tpkk/2016_us

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To TMCnet.com's Homepage ]